GR1011042B - Αντιικος παραγοντας με φυσικα συστατικα σε μορφη σπρεϊ για ρινικη εφαρμογη - Google Patents
Αντιικος παραγοντας με φυσικα συστατικα σε μορφη σπρεϊ για ρινικη εφαρμογηInfo
- Publication number
- GR1011042B GR1011042B GR20240100470A GR20240100470A GR1011042B GR 1011042 B GR1011042 B GR 1011042B GR 20240100470 A GR20240100470 A GR 20240100470A GR 20240100470 A GR20240100470 A GR 20240100470A GR 1011042 B GR1011042 B GR 1011042B
- Authority
- GR
- Greece
- Prior art keywords
- virus particles
- cov
- entry
- protective film
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Η εφεύρεση αφορά τη σύνθεση και παρασκευή ενός προϊόντος σπρέι, το οποίο χαρακτηρίζεται από αντιικές ιδιότητες και εφαρμόζεται στη ρινική κοιλότητα. Το σπρέι λειτουργεί απωθώντας τα σωματίδια του ιού και παρεμποδίζοντας την αλληλεπίδραση των υποδοχέων του ξενιστή με τις ιικές πρωτεΐνες που είναι υπεύθυνες για την είσοδο των ιικών σωματιδίων στα ανθρώπινα κύτταρα. Τα αιθέρια έλαια ευκαλύπτου, κανέλας και λεβάντας είναι γνωστά για την αντιική τους δράση σε κατάσταση ατμού, επομένως έχουν επιλεγεί για να «παγιδεύουν» και να απωθούν τα ιικά σωματίδια πριν εισέλθουν στον ανθρώπινο οργανισμό. Επιπλέον, περιέχει ένα φυτικό συστατικό, το οποίο δημιουργεί ένα προστατευτικό φιλμ στο βλενογόννο της μύτης παρεμποδίζοντας την είσοδο των σωματιδίων του ιού στον ανθρώπινο οργανισμό. Συγκεκριμένα, περιέχει τα έλαια περγαμόντου και τεϊόδεντρου, τα οποία είναι γνωστά για την ανασταλτική του δράση κατά του SARS-CoV-2 και του Η1Ν1, επηρεάζοντας τις οδούς του μηχανισμού μόλυνσης. Επίσης, περιέχει αιθέριο έλαιο θυμαριού, που έχει ιοκτόνο δράση έναντι του SARS-CoV-2 και του ιού της γρίπης. Τέλος, για την δημιουργία του προστατευτικού φιλμ, που αναφέρθηκε παραπάνω, χρησιμοποιήθηκε η yota-carrageenan ένας θειικός πολυσακχαρίτης υψηλού μοριακού βάρους, που προέρχεται από κόκκινα φύκια (Rhodophyceae) και chitosan και ουλβάνες. Η σύνθεσή του στοχεύει κυρίως στον ιό της γρίπης τύπου Α και Β, σε ρινοϊούς και κορονοϊούς.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20240100470A GR1011042B (el) | 2024-06-30 | 2024-06-30 | Αντιικος παραγοντας με φυσικα συστατικα σε μορφη σπρεϊ για ρινικη εφαρμογη |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20240100470A GR1011042B (el) | 2024-06-30 | 2024-06-30 | Αντιικος παραγοντας με φυσικα συστατικα σε μορφη σπρεϊ για ρινικη εφαρμογη |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1011042B true GR1011042B (el) | 2025-09-23 |
Family
ID=97491619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20240100470A GR1011042B (el) | 2024-06-30 | 2024-06-30 | Αντιικος παραγοντας με φυσικα συστατικα σε μορφη σπρεϊ για ρινικη εφαρμογη |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1011042B (el) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
| US20060120967A1 (en) * | 2004-12-07 | 2006-06-08 | Qpharma, Llc | Solution forms of cyclodextrins for nasal or throat delivery of essential oils |
| US20130156868A1 (en) * | 2010-09-07 | 2013-06-20 | Krewel Mueselbach GmbH | Nasal spray |
| US20210315955A1 (en) * | 2020-04-10 | 2021-10-14 | Bert Forman | Compositions and methods for treatment of respiratory ailments |
| WO2022099182A1 (en) * | 2020-11-09 | 2022-05-12 | Rucker Capital Advisors | Oral rinse, nasal spray and methods for prevention of covid-19 by lowering viral load of covid-19 |
| WO2023031929A1 (en) * | 2021-08-31 | 2023-03-09 | Polyrizon Ltd. | Mucoadhesive polymers for nasal drug delivery |
| US20240058385A1 (en) * | 2022-08-09 | 2024-02-22 | Core Consumer Healthcare LLC | Anti-viral compositions and methods |
-
2024
- 2024-06-30 GR GR20240100470A patent/GR1011042B/el active IP Right Grant
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
| US20060120967A1 (en) * | 2004-12-07 | 2006-06-08 | Qpharma, Llc | Solution forms of cyclodextrins for nasal or throat delivery of essential oils |
| US20130156868A1 (en) * | 2010-09-07 | 2013-06-20 | Krewel Mueselbach GmbH | Nasal spray |
| US20210315955A1 (en) * | 2020-04-10 | 2021-10-14 | Bert Forman | Compositions and methods for treatment of respiratory ailments |
| WO2022099182A1 (en) * | 2020-11-09 | 2022-05-12 | Rucker Capital Advisors | Oral rinse, nasal spray and methods for prevention of covid-19 by lowering viral load of covid-19 |
| WO2023031929A1 (en) * | 2021-08-31 | 2023-03-09 | Polyrizon Ltd. | Mucoadhesive polymers for nasal drug delivery |
| US20240058385A1 (en) * | 2022-08-09 | 2024-02-22 | Core Consumer Healthcare LLC | Anti-viral compositions and methods |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reichling | Antiviral and virucidal properties of essential oils and isolated compounds–a scientific approach | |
| Mani et al. | Natural product-derived phytochemicals as potential agents against coronaviruses: A review | |
| Elsebai et al. | Essential oils and COVID-19 | |
| Omar et al. | In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2 | |
| BR112022015764A2 (pt) | Construções de ácido nucleico, vetores, vírus do sarampo, composições imunogênicas, processos para recuperar o vírus do sarampo, moléculas de ácido nucleico, polipeptídeos, proteínas recombinantes, usos in vitro de um antígeno, métodos para tratar ou prevenir uma infecção e para induzir uma resposta imune protetora | |
| KR20070102487A (ko) | 질병 전염률을 감소시키는 조성물 및 그 방법 | |
| Kaur et al. | Antiviral essential oils incorporated in nanocarriers: Strategy for prevention from COVID-19 and future infectious pandemics | |
| Bhat et al. | Immunomodulators for curtailing COVID-19: a positive approach | |
| Chakraborty et al. | Fighting the flu: a brief review on anti-influenza agents | |
| BR112022005941A2 (pt) | Compostos do conjugado para prevenir e/ou tratar infecções por hbv e/ou hdv, doenças hepáticas e para direcionar ntcp | |
| GR1011042B (el) | Αντιικος παραγοντας με φυσικα συστατικα σε μορφη σπρεϊ για ρινικη εφαρμογη | |
| EA201700340A1 (ru) | Биологически активное вещество полифармакологического действия растительного происхождения | |
| Singh | Role of Rubia cordifolia Linn. in radiation protection | |
| Gabbianelli et al. | Plant-derived epi-nutraceuticals as potential broad-spectrum anti-viral agents | |
| Aggarwal et al. | Natural products as potential therapeutic agents for SARS-CoV-2: a medicinal chemistry perspective | |
| Gopal et al. | Anti-COVID-19 credentials of chitosan composites and derivatives: future scope? | |
| Saini et al. | Current status of potential antiviral drugs derived from plant, marine, and microbial sources | |
| Kaur et al. | Phytochemicals and phyto-essential oils as potent antiviral agents | |
| PH12022550269A1 (en) | Antiviral & virucidal nasal spray compositions and related treatment methods | |
| Elengoe | Indian spices boost the immune system against covid-19 | |
| Biswal et al. | Natural products based antibacterial and antiviral materials | |
| A Marathe et al. | Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases | |
| Akram et al. | Herbal Remedies with potential COVID-19 activities | |
| WO2022263916A1 (en) | A synergistic phytoextract formulation for anti-inflammatory action | |
| Turkson et al. | COVID-19: The role of medicinal plants and research institutions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PG | Patent granted |
Effective date: 20251009 |